ArticleOncoimmunology2026

Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic melanoma.

Juan Luis Onieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.